Method for ablating with needle electrode

Patent metadata

Field	Value
Publication number	US-9326813-B2
Application number	US-73958707-A
Country	US
Kind code	B2
Filing date	Apr 24, 2007
Priority date	Oct 27, 2003
Publication date	May 3, 2016
Grant date	May 3, 2016

Abstract

A method for ablating tissue in or around the heart to create an enhanced lesion is provided. The distal end of a catheter including a needle electrode at its distal end is introduced into the heart. The distal end of the needle electrode is introduced into the tissue. An electrically-conductive fluid is infused through the needle electrode and into the tissue. The tissue is ablated after and/or during introduction of the fluid into the tissue. The fluid conducts ablation energy within the tissue to create a larger lesion than would be created without the introduction of the fluid.

First claim

What is claimed is:

1. A method for ablating tissue in or around the heart comprising:
introducing into the heart a distal end of a catheter, the catheter comprising:
a proximal shaft,
a distal shaft distal the proximal shaft and comprising a distal shaft tubing having an infusion lumen and at least one second lumen off-axis from the infusion lumen, the distal shaft terminating in the distal end of the catheter, and
a needle electrode assembly, the needle electrode assembly comprising a proximal tubing having a distal end longitudinally spaced from and aligned with a proximal end of a distal tubing, wherein fluid can pass from the distal end of the proximal tubing to a longitudinal space between the distal end of the proximal tubing and the proximal end of the distal tubing to the proximal end of the distal tubing, the proximal tubing being more flexible than the distal tubing, wherein the distal tubing comprises at least one irrigation port in a sidewall of the tubing, the proximal tubing extending through the proximal shaft into the infusion lumen in the distal shaft, the distal tubing of the needle electrode assembly being in a retracted position within the distal shaft, the needle electrode assembly further comprising an outer tubing in which the distal end of the proximal tubing and the proximal end of the distal tubing are fixedly mounted to form a single structure that is longitudinally moveable relative to the proximal shaft;

introducing a distal end of the distal tubing of the needle electrode assembly into the tissue, including moving the distal tubing from its retracted position within the distal shaft to an extended position outside the distal shaft;
infusing into the tissue an electrically-conductive fluid through the distal tubing of the needle electrode assembly while in the extended position; and
ablating the tissue after and/or during introduction of the fluid into the tissue, whereby the fluid conducts ablation energy within the tissue to create a larger lesion than would be created without the introduction of the fluid.

2. The method according to claim 1 , wherein the distal tubing of the needle electrode assembly comprises a closed distal face.

3. The method according to claim 1 , wherein the distal tubing of the needle electrode assembly comprises an opening at a distal face of the tubing.

4. The method according to claim 1 , wherein the tissue is ablated using the needle electrode assembly.

5. The method according to claim 1 , wherein the tissue is ablated using a tip electrode on the distal end of the catheter.

6. The method according to claim 1 , wherein the fluid is infused through the needle electrode assembly during ablation.

7. The method according to claim 1 , wherein the fluid is infused through the needle electrode assembly before ablation.

8. The method according to claim 1 , wherein the fluid is infused through the needle electrode assembly before and during ablation.

9. The method according to claim 1 , wherein the fluid infused through the needle electrode assembly comprises saline having a salt content ranging from about 0.3 to about 4 wt %.

10. The method according to claim 1 , wherein the fluid infused through the needle electrode assembly comprises a radiographic contrast agent.

11. The method according to claim 10 , wherein the amount of the contrast agent present in the fluid ranges from about 5 to about 50%.

12. The method according to claim 1 , wherein the fluid is infused through the needle electrode assembly at a rate ranging from about 0.3 to about 5 ml/min.

13. The method according to claim 1 , wherein radio frequency energy is introduced to the needle electrode assembly at a power up to about 70 watts.

14. The method according to claim 1 , wherein radiofrequency energy is introduced to the needle electrode assembly for at least about 15 seconds.

15. The method according to claim 4 , further comprising burning a surface lesion with a tip electrode on the catheter, wherein the surface lesion is burned at an endocardial surface of the tissue ablated with the needle electrode assembly.

16. The method according to claim 1 , further comprising taking an impedance measurement using the needle electrode assembly before, during and/or after introduction of the distal end of the needle electrode assembly into the tissue.

17. The method according to claim 16 , further comprising adjusting a flow rate of the fluid infused through the needle electrode assembly, and/or an amount of power delivered to the needle electrode assembly, and/or the time over which the fluid is infused and/or the power delivered in response to the impedance measurement.

18. The method according to claim 1 , further comprising measuring a temperature of the needle electrode assembly during ablation.

19. The method according to claim 18 , further comprising adjusting a flow rate of the fluid infused through the needle electrode assembly, and/or an amount of power delivered to the needle electrode assembly, and/or the time over which the fluid is infused and/or the power delivered in response to the temperature measurement.

20. The method according to claim 19 , wherein the needle electrode assembly is maintained at a temperature ranging from about 35 to about 90° C.

21. The method according to claim 1 , further comprising measuring electrical activity using the needle electrode assembly before and/or after ablation.

22. The method according to claim 1 , further comprising pacing using the needle electrode assembly before and/or after ablation.

Assignees

• Pike Jr Robert W
• Sapp Jr John L
• Stevenson William G
• Mest Robert A
• Biosense Webster Inc
• Brigham & Womens Hospital

Inventors

• Pike Jr Robert W
• Sapp Jr John L
• Stevenson William G
• Mest Robert A

Classifications

• A61B2018/00351

  Heart · CPC title

• A61B2018/1425

  Needle · CPC title

• A61B18/1492 Primary

  having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence) · CPC title

• A61B2018/1472

  for use with liquid electrolyte, e.g. virtual electrodes · CPC title

• A61B18/1477

  Needle-like probes · CPC title